⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9835844 | 1.00 | — | — | |
| SCHEMBL4674692 | 0.92 | — | — | |
| SCHEMBL14398018 | 0.90 | HPGD (0.42) | — | |
| SCHEMBL3664692 | 0.81 | TP53 (0.39) | — | |
| SCHEMBL2546819 | 0.78 | TP53 (0.30) | — | |
| SCHEMBL329231 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL14844794 | 0.75 | NOS3 (0.48) | — | |
| SCHEMBL31128189 | 0.73 | ALDH1A1 (0.50) | — | |
| SCHEMBL883443 | 0.72 | — | — | |
| SCHEMBL12762365 | 0.70 | NOS3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4219735-B1 | METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR | ABBOTT DIABETES CARE (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| CN-118005607-B | Process for the preparation of (S) -nicotine from myosmine | 扎诺普瑞玛生命科学有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-113950534-B | Method for producing L-type cyclic amino acid | 株式会社API | 2025-05-20 | — | — | CN | disclosed |
| EP-4538692-A2 | METHOD AND APPARATUS FOR ANALYTE DETECTION USING AN ELECTROCHEMICAL BIOSENSOR | Abbott Diabetes Care (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | disclosed |
| EP-4419487-A1 | SYSTEMS AND METHODS FOR BIOREMEDIATION OF PER- AND POLYFLUOROALKYL SUBSTANCES AND 1,4-DIOXANE | The Trustees Of Columbia University In The City Of New York (US) | 2024-08-28 | — | — | EP | disclosed |
| CN-118005607-A | Process for the preparation of (S) -nicotine from myosmine | 扎诺普瑞玛生命科学有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-20230277125-A1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIVERSITÄTS-KINDERSPITAL BEIDER BASEL (CH) | 2023-09-07 | — | — | US | disclosed |
| WO-2010048582-A1 | BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES | IRM LLC (BM) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010048582-A1 | BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES | IRM LLC (BM) | 2010-04-29 | — | — | WO | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| EP-1629092-A2 | CRYSTALLOGRAPHIC STRUCTURE OF TRYPANOSOMA CRUZI PROLINE RACEMASE (TcPRACA) AND USES THEREOF | INSTITUT PASTEUR (FR) | 2006-03-01 | — | — | EP | disclosed |
| EP-1592788-A2 | IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE | INSTITUT PASTEUR (FR) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004106506-A2 | CRYSTALLOGRAPHIC STRUCTURE OF TRYPANOSOMA CRUZI PROLINE RACEMASE (TCPRACA) AND USES THEREOF | INSTITUT PASTEUR (FR) | 2004-12-09 | — | — | WO | disclosed |
| WO-2004072223-A2 | IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE | INSTITUT PASTEUR (FR) | 2004-08-26 | — | — | WO | disclosed |
| EP-0307390-A2 | Chemical compound consisting of cis-3-hydroxyproline for therapeutic treatment, and process for its preparation | MERCKLE GMBH (DE) | 1989-03-15 | — | — | EP | disclosed |